Literature DB >> 10866023

Why, why, why?: Reason-giving and rumination as predictors of response to activation- and insight-oriented treatment rationales.

M E Addis1, K M Carpenter.   

Abstract

This study examines the relationships among the reasons a person offers for depression, the tendency to ruminate in response to depression, and reactions to activation-oriented (AO) or insight-oriented (IO) treatment rationales. Adults from the community (N=51) completed self-report measures of reason-giving and rumination and rated the credibility of, and personal reactions to, AO and IO rationales presented in written and videotape formats. Participants who gave more reasons for depression also tended to ruminate more in response to depressed mood. Reason-giving and rumination predicted lower credibility ratings and more negative personal reactions to the AO rationale. Although no relationship was found between these variables and response to the IO rationale, specific reasons were associated with different reactions to the two rationales. We discuss the roles of reason-giving and rumination in predicting responses to psychotherapies for depression.

Entities:  

Mesh:

Year:  1999        PMID: 10866023     DOI: 10.1002/(sici)1097-4679(199907)55:7<881::aid-jclp9>3.0.co;2-e

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  11 in total

1.  Are PTSD treatment choices and treatment beliefs related to depression symptoms and depression-relevant treatment rationales?

Authors:  Nina K Rytwinski; Cari B Rosoff; Norah C Feeny; Lori A Zoellner
Journal:  Behav Res Ther       Date:  2014-08-01

2.  Effects of Intervention Characteristics on Willingness to Initiate a Weight Gain Prevention Program.

Authors:  Megan A McVay; Marissa L Donahue; JeeWon Cheong; Joseph Bacon; Michael G Perri; Kathryn M Ross
Journal:  Am J Health Promot       Date:  2020-02-20

3.  Could Treatment Matching Patients' Beliefs About Depression Improve Outcomes?

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Michael E Thase; Robin B Jarrett
Journal:  Behav Ther       Date:  2018-12-08

4.  Overcoming barriers to disseminating exposure therapies for anxiety disorders: a pilot randomized controlled trial of training methods.

Authors:  Melanie S Harned; Linda A Dimeff; Eric A Woodcock; Julie M Skutch
Journal:  J Anxiety Disord       Date:  2011-03

5.  Does change in distress matter? Mechanisms of change in prolonged exposure for PTSD.

Authors:  Ellen J Bluett; Lori A Zoellner; Norah C Feeny
Journal:  J Behav Ther Exp Psychiatry       Date:  2013-09-13

6.  Providing a treatment rationale for PTSD: does what we say matter?

Authors:  Norah C Feeny; Lori A Zoellner; Shoshana Y Kahana
Journal:  Behav Res Ther       Date:  2009-06-21

7.  What you believe is what you want: modeling PTSD-related treatment preferences for sertraline or prolonged exposure.

Authors:  Lori A Zoellner; Norah C Feeny; Joyce N Bittinger
Journal:  J Behav Ther Exp Psychiatry       Date:  2009-06-12

8.  Patient factors associated with initiation of behavioral weight loss treatment: a prospective observational study in an integrated care setting.

Authors:  Megan A McVay; William S Yancy; Christine N Scott; Lindsay Wilson-Barlow; Sandra Woolson; W Clint McSherry; Sandra Allen; Corrine I Voils
Journal:  Transl Behav Med       Date:  2017-03       Impact factor: 3.046

9.  "How will it help me?" Reasons underlying treatment preferences between sertraline and prolonged exposure in posttraumatic stress disorder.

Authors:  Jessica A Chen; Stephanie M Keller; Lori A Zoellner; Norah C Feeny
Journal:  J Nerv Ment Dis       Date:  2013-08       Impact factor: 2.254

10.  The effects of positive patient testimonials on PTSD treatment choice.

Authors:  Larry D Pruitt; Lori A Zoellner; Norah C Feeny; Daniel Caldwell; Robert Hanson
Journal:  Behav Res Ther       Date:  2012-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.